Methysergide delays the decompensatory responses to severe hemorrhage by activating 5-HT(1A) receptors

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 279, Issue 5 48-5, 2000, Pages

  Scrogin, Karie E ^a,c   Johnson, Alan Kim ^b   Brooks, Virginia L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Renal sympathetic activity; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; METHYSERGIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD VOLUME; BRADYCARDIA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE;

EID: 0033672557     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.279.5.r1776     Document Type: Article

References (45)

1. 1 receptor subtype coupled to the inhibition of adenylate cyclase
2. The cloned human 5-HT(1E) receptor couples to inhibition and activation of adenylyl cyclase via two distinct pathways in transfected BS-C-1 cells
3. 2/5-HT(1C) receptors to release vasopressin in anaesthetized rats
4. 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex
5. 3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum
6. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex
7. Evidence for the existence of 5-hydroxytryptamine receptors, which are not of the 5-HT2 type, mediating contraction of rabbit isolated basilar artery
8. 5-Hydroxytryptamine-induced Cl-transport is mediated by 5-HT3 and 5-HT4 receptors in the rat distal colon
9. GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not D-amphetamine-induced hyperlocomotion, in the Wistar-Kyoto hyperactive (WKHA) rat
10. Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists
11. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin on the cholinergic contraction in guinea pig and human airways in vitro
12. The use of antiserotonergic agents for the treatment of acute hemorrhagic shock of cats
13. Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain
14. Effects of alpha-adrenoceptor antagonists and clonidine on the haemodynamic response to acute hypovolaemia in conscious rabbits
15. Effects of 5-HT-receptor and alpha 2-adrenoceptor ligands on the haemodynamic response to acute central hypovolaemia in conscious rabbits
16. A CNS serotonergic mechanism in acute central hypovolemia in conscious rabbits?
17. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
18. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: Site of action and pharmacological analysis
19. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat
20. Contractile 5-HT1 receptors in human isolated pial arterioles: Correlation with 5-HT1D binding sites
21. 5-HT1 receptors mediating contraction in bovine cerebral arteries: A model for human cerebrovascular '5-HT1D beta' receptors
22. Hypotensive effects of 5-HT1A receptor activation: Ventral medullary sites and mechanisms of action in the rat
23. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
24. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding
25. Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype
26. Repeated measurements and multiple comparisons in cardiovascular research
27. Further investigation into the signal transduction mechanism of the 5-HT4-like receptor in the circular smooth muscle of human colon
28. Serotonergic mechanisms mediate renal sympathoinhibition during severe hemorrhage in rats
29. Role of ventrolateral medulla in sympatholytic effect of 8-OHDPAT in rats
30. Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving cat
31. The effects of ketanserin, methysergide and LY 53857 on sympathetic nerve activity
32. Serotonin receptors: Subtypes, functional responses and therapeutic relevance
33. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors
34. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals
35. Hemodynamic effects of hemorrhage and subsequent naloxone treatment in conscious rabbits
36. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus
37. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists
38. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: Do discriminatory 5-HT1B receptor ligands exist?
39. Central serotonin injection produces sustained inhibition of renal sympathetic activity in volume-depleted rats
40. Central methysergide prevents renal sympathoinhibition and bradycardia during hypotensive hemorrhage
41. Neurocardiogenic syncope
42. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat
43. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: Role of 5-HT1B/1D receptors and alpha2-adrenoceptors
44. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat
45. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine 1E receptor